Market Cap | 23.42B | P/E | 21.29 | EPS this Y | - | Ern Qtrly Grth | -55.40% |
Income | 1.08B | Forward P/E | 31.64 | EPS next Y | - | 50D Avg Chg | 14.00% |
Sales | 9.8B | PEG | - | EPS past 5Y | 9.46% | 200D Avg Chg | -9.00% |
Dividend | 8.00% | Price/Book | 2.40 | EPS next 5Y | 10.80% | 52W High Chg | -41.00% |
Recommedations | 1.00 | Quick Ratio | 1.13 | Shares Outstanding | 691.88M | 52W Low Chg | 27.00% |
Insider Own | - | ROA | 4.02% | Shares Float | 688.74M | Beta | 0.79 |
Inst Own | 0.16% | ROE | 11.89% | Shares Shorted/Prior | -/- | Price | 33.85 |
Gross Margin | 33.92% | Profit Margin | 11.41% | Avg. Volume | 254,643 | Target Price | 44.00 |
Oper. Margin | 10.48% | Earnings Date | - | Volume | 56,591 | Change | 3.30% |
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.